Glucose-6-Phosphate Dehydrogenase
| Label Mnemonic: | G6PDA |
| Epic code: | LAB3221 |
| Downtime form: | Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
6240-8 RCP
356-8593
![]() |
| Lavender top tube 3 mL (EDTA) |
Preferred Minimum: 3 mL whole blood
Absolute Minimum: 1.5 mL whole blood
Clotted or hemolyzed specimens.
1-3 days upon receipt at reference laboratory
| Age | Reference Intervals (U/g Hb) |
|---|---|
| Less than 8 days | 16.4 - 24.1 |
| 8 - 30 days | 13.6 - 23.9 |
| 1 - 6 months | 11.5 - 21.5 |
| 7 - 12 months | 10.3 - 17.9 |
| 1 - 17 years | 9.7 - 16.9 |
| Greater than or equal to 18 years | 9.6 - 16.3 |
World Health Organization guidance on classification of G6PD activity is as follows:
Males: G6PD activity less than 30% of the normal median are regarded as G6PD deficient. Males with G6PD activity of 30% or more of the normal median can be regarded as G6PD normal.
Females: G6PD activity less than 30% of the normal median are regarded as G6PD deficient. Females with G6PD activity of 80% or more of the normal median can be regarded as G6PD normal. G6PD activity between 30% and 80% of the normal median are regarded as intermediate activity.
Cutoffs and results are specific to this G6PD assay and configuration and cannot be used interchangeably across different assays, parameters, and/or instrument configurations.
Reference: Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure. Geneva: World Health Organization; 2018. ISBN 978-92-4-151428-6
| Percent of Normal Activity (U/g Hb) | |||
|---|---|---|---|
| Age | 100% | 80% | 30% |
| <8 days | 19.7 | 15.8 | 5.9 |
| 8 - 30 days | 18.2 | 14.6 | 5.5 |
| 1 - 6 months | 16.1 | 12.9 | 4.8 |
| 7 - 12 months | 13.8 | 11.0 | 4.1 |
| 1 - 17 years | 12.9 | 10.3 | 3.9 |
| 18 years | 12.7 | 10.2 | 3.8 |
| Percentage of normal activity cutoffs to G6PD enzyme activity. 100% for males and females is defined as the 50th percentile of non-affected males. | |||
Quantitative Enzymatic

Note: Patients who have recently received transfusions have normal donor cells that may mask G-6-PD deficient erythrocytes.